Literature DB >> 15608363

Disturbances of the parasympathetic branch of the autonomic nervous system in patients with gastroesophageal reflux disease (GERD) estimated by short-term heart rate variability recordings.

L Dobrek1, M Nowakowski, M Mazur, R M Herman, P J Thor.   

Abstract

Gastro-esophageal reflux disease (GERD) is the result of the acid contents regurgitation back from the stomach into the esophagus. According to the endoscopic findings, GERD can be divided into two main forms: non-erosive (NERD) and erosive reflux esophagitis. The pathogenesis of GERD is associated with the impaired function of the antireflux barrier. Disturbances of the autonomic nervous system (ANS), especially parasympathetic part of the ANS, may be also involved in the pathogenesis of this disease. The aim of our study was to establish the parasympathetic activity in patients with reflux esophagitis and in patients with symptomatic endoscopically negative reflux. Working hypothesis was the question, whether the possible parasympathetic activity disturbances, which are observed in all GERD patients, may be regarded as the primary or secondary to the esophagitis. All the participants (20 pts. with NERD, 20 pts. with reflux esophagitis and 20 healthy controls) underwent esophageal manometry, 24-hour ambulatory pH-monitoring, resting heart rate variability (HRV) recording and the deep breathing (DB) test with the continuous HRV recording. The results of the spectral analysis both of the short-term, resting HRV recordings and DB-evoked revealed the disturbances of the main power spectra components - LF and HF in both groups of patients in comparison with the control group. In our opinion, the observed HRV spectra changes in both groups of patients support the hypothesis that not only is the parasympathetic activity impairment associated with the pathogenesis of GERD but it is also the primary factor contributing to the pathophysiological mechanism of reflux.

Entities:  

Mesh:

Year:  2004        PMID: 15608363

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  7 in total

1.  Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction.

Authors:  A Min Wang; Gang Wang; Ning Huang; Yan Yan Zheng; Fan Yang; Xia Qiu; Xian Ming Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-06-08       Impact factor: 2.503

2.  Cardiac autonomic dysfunction in patients with gastroesophageal reflux disease.

Authors:  Branislav Milovanovic; Branka Filipovic; Slavica Mutavdzin; Marija Zdravkovic; Tatjana Gligorijevic; Jovana Paunovic; Marina Arsic
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

3.  Autonomic function, gastroesophageal reflux in apparent life threatening event.

Authors:  Emanuel Tirosh; Noga Ariov-Antebi; Ayala Cohen
Journal:  Clin Auton Res       Date:  2010-02-03       Impact factor: 4.435

4.  Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Authors:  I M Modlin; R H Hunt; P Malfertheiner; P Moayyedi; E M Quigley; G N J Tytgat; J Tack; R C Heading; G Holtman; S F Moss
Journal:  Digestion       Date:  2009-06-17       Impact factor: 3.216

5.  How is the autonomic nerve function different between gastroesophageal reflux disease alone and gastroesophageal reflux disease with diabetes mellitus neuropathy?

Authors:  Meiyun Ke
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

6.  Higher Dementia Risk in People With Gastroesophageal Reflux Disease: A Real-World Evidence.

Authors:  Shuo-Yan Gau; Jung-Nien Lai; Hei-Tung Yip; Meng-Che Wu; James Cheng-Chung Wei
Journal:  Front Aging Neurosci       Date:  2022-04-04       Impact factor: 5.750

7.  Involvement of autonomic nervous activity changes in gastroesophageal reflux in neonates during sleep and wakefulness.

Authors:  Djamal-Dine Djeddi; Guy Kongolo; Erwan Stéphan-Blanchard; Mohamed Ammari; André Léké; Stéphane Delanaud; Véronique Bach; Frederic Telliez
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.